Although osteosarcoma cells were highly sensitive to combined antagonism of MCL-1 and BCL-xL, dual targeting of these proteins can be hepatotoxic [77], which could complicate clinical translation of this finding. Here, BCL2L1 is linked to osteosarcoma.